APA (7th ed.) Citation

Xie, R., Cai, W., Ouyang, Y., Zou, Y., & Sun, R. Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma. BMC.

Chicago Style (17th ed.) Citation

Xie, Rui-Ling, Wu-Lin Cai, Yan-Feng Ouyang, Ye-Hao Zou, and Rui Sun. Effect and Safety of Immunotherapy Among Elder Patients (age ≥ 65) with Recurrent or Metastatic Nasopharyngeal Carcinoma. BMC.

MLA (9th ed.) Citation

Xie, Rui-Ling, et al. Effect and Safety of Immunotherapy Among Elder Patients (age ≥ 65) with Recurrent or Metastatic Nasopharyngeal Carcinoma. BMC.